Patient Disease Trajectories in Baricitinib-2mg-treated Patients with Rheumatoid Arthritis and Inadequate Response to csDMARDs

被引：0

作者：

Pope, Janet ^{[1
]}

Li, Zhanguo ^{[2
]}

Genovese, Mark ^{[3
]}

Otawa, Susan ^{[4
]}

Sun, Luna ^{[5
]}

Chandran, Shelly ^{[6
]}

Keystone, Edward ^{[7
]}

Dougados, Maxime ^{[8
]}

机构：

[1] Western Univ, Dept Med, Div Rheumatol, London, ON, Canada

[2] Peking Univ, Peoples Hosp, Beijing, Peoples R China

[3] Stanford Univ, Palo Alto, CA 94304 USA

[4] Eli Lilly & Co, Mississauga, ON, Canada

[5] Eli Lilly & Co, Indianapolis, IN 46285 USA

[6] Eli Lilly Canada Inc, Toronto, ON, Canada

[7] Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada

[8] Hop Cochin, Paris, France

来源：

JOURNAL OF RHEUMATOLOGY | 2020年 / 47卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

235

引用

页码：1127 / 1128

页数：2

共 50 条

[1] Patient Disease Trajectories in Baricitinib 2-mg-Treated Patients with Rheumatoid Arthritis and Inadequate Response to Biologic DMARDs
Genovese, Mark
Weinblatt, Michael
Wu, Jianmin
Jia, Bochao
Quebe, Amanda
Sun, Luna
Chen, Yun-Fei
Helt, Cameron
Griffing, Kirstin
Reis, Paulo
Pope, Janet
JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1129 - 1129
[2] Patient Disease Trajectories in Baricitinib-2 Mg-Treated Patients with Rheumatoid Arthritis and Inadequate Response to Biologic DMARDs
Genovese, Mark
Weinblatt, Michael
Wu, Jianmin
Jia, Bochao
Quebe, Amanda
Sun, Luna
Chen, Yun-Fei
Helt, Cameron
Bacani, A. Kirstin
Reis, Paulo
Pope, Janet
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[3] PATIENT DISEASE TRAJECTORIES IN BARICITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE
Taylor, Peter C.
Emery, Paul
Weinblatt, Michael E.
Mysler, Eduardo
Rubbert-Roth, Andrea
Jia, Bochao
Sun, Luna
Liu, Yushi
Chen, Yun-Fei
Cardoso, Anabela
Tanaka, Yoshiya
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 322 - 323
[4] Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics
Kremer, Joel M.
Schiff, Michael
Muram, David
Zhong, Jinglin
Alam, Jahangir
Genovese, Mark C.
RMD OPEN, 2018, 4 (01):
[5] Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies
Taylor, Peter C.
Chen, Yun-Fei
Pope, Janet
Weinblatt, Michael
Mysler, Eduardo
Rubbert-Roth, Andrea
Jia, Bochao
Sun, Luna
Liu, Yushi
Holzkamper, Thorsten
Tanaka, Yoshiya
RHEUMATOLOGY AND THERAPY, 2023, 10 (02) : 463 - 476
[6] Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies
Peter C. Taylor
Yun-Fei Chen
Janet Pope
Michael Weinblatt
Eduardo Mysler
Andrea Rubbert-Roth
Bochao Jia
Luna Sun
Yushi Liu
Thorsten Holzkämper
Yoshiya Tanaka
Rheumatology and Therapy, 2023, 10 : 463 - 476
[7] RAPID RESPONSE WITH UPADACITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO CSDMARDS OR BDMARDS
FitzGerald, O.
Rubbert-Roth, A.
Chen, K.
Meerwein, S.
Enejosa, J.
Shaw, T.
Wells, A. F.
RHEUMATOLOGY, 2019, 58 : 65 - 65
[8] Rapid Response With Upadacitinib Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to csDMARDs or bDMARDs
FitzGerald, O.
Rubbert-Roth, A.
Chen, K.
Meerwein, S.
Enejosa, J.
Shaw, T.
Wells, A.
SWISS MEDICAL WEEKLY, 2018, 148 : 22S - 22S
[9] BARICITINIB INHIBITS RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE AT 1 YEAR IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO CSDMARDS
van der Heijde, D.
Dougados, M.
Chen, Y. -C.
Greenwald, M.
Drescher, E.
Klar, R.
Xie, L.
de la Torre, I.
Rooney, T. P.
Witt, S.
Schlichting, D.
DeBono, S.
Emery, P.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 244 - 245
[10] Rapid Response with Upadacitinib Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to csDMARDs or bDMARDs
FitzGerald, Oliver
Rubbert-Roth, Andrea
Chen, Kun
Meenwein, Sebastian
Enejosa, Jose Jeffrey
Shaw, Tim
Wells, Alvin F.
ARTHRITIS & RHEUMATOLOGY, 2018, 70

← 1 2 3 4 5 →